SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurogen (NRGN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Thomas M. who wrote (161)4/30/1998 9:35:00 PM
From: phbolton  Read Replies (2) of 523
 
Thomas: Don't know. It looks like someone/fund bought about 100k today most of the action was in a handful of trades. Last trade was 25k at 18.5. Phase II results on 91-2 (anxiety), 94-4 (schizophrenia) and ADCI (epilepsy) should be out in the next few months but all are being carried out by their partners so the time lines are difficult to guess but its often 8-14 months for phase II results after completion of phase I. A follow up candidate to 95-1 (obesity) should be announced one of these days. No one can accuse these guys of hype.
There was a press release last week about another collaboration:
neurogen.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News